Professional Documents
Culture Documents
A. Telaah Umum
N Pertanyaan Pembahasan
o
1. Identitas Jurnal
Judul Probiotic Supplementation in Neonates with Congenital
Gastrointestinal Surgical Conditions: A Pilot Randomised
Controlled Trial
4. Chung, E. Y. & Yardley, J. Are there risks associated with empiric acid
suppression treatment of infants and children suspected of having
gastroesophageal reflflux disease. Hosp. Pediatr. 3, 16–23 (2013).
17. Tan, J. et al. The role of short-chain fatty acids in health and disease.
Adv. Immunol. 121, 91–119 (2014).
18. Nogal, A., Valdes, A. M. & Menni, C. The role of short-chain fatty
acids in the interplay between gut microbiota and diet in cardio-metabolic
health. Gut Microbes 13, 1–24 (2021).
19. Tsukuda, N. et al. Key bacterial taxa and metabolic pathways affecting
gut shortchain fatty acid profifiles in early life. ISME J. 15, 2574–2590
(2021).
34. Wejryd, E., Marchini, G., Frimmel, V., Jonsson, B. & Abrahamsson,
T. Probiotics promoted head growth in extremely low birthweight infants
in a double-blind placebo-controlled trial. Acta Paediatr. 108, 62–69
(2019).
35. Guney Varal, I., Koksal, N., Ozkan, H., Bagci, O. & Dogan, P.
Potential use of multistrain synbiotics for improving postnatal head
circumference. Pak. J. Med. Sci. 34, 1502–1506 (2018).
40. Jenke, A., Ruf, E. M., Hoppe, T., Heldmann, M. & Wirth, S.
Bififidobacterium septicaemia in an extremely low-birthweight infant
under probiotic therapy. Arch. Dis. Child. Fetal Neonatal Ed. 97, F217–
F218 (2012).
45. Shaterian, N., Abdi, F., Ghavidel, N. & Alidost, F. Role of cesarean
section in the development of neonatal gut microbiota: a systematic
review. Open Med. (Wars.) 16, 624–639 (2021).
B. Analisis PICO
Patient 61 Neonatus (usia gestasi ≥35 minggu) dengan
intestinal atresia, malrotation, congenital
diaphragmatic hernia (CDH), tracheoesophageal
fistula (TOF), gastroschisis, exomphalos,
Hirschsprung disease, imperforate anus, short bowel
syndrome, dan kondisi lain yang memerlukan stoma
(e.g.,severe meconium ileus, microcolon) di Perth
Children’s Hospital, Western Australia
Intervention Kelompok Probiotik (30) diberikan probiotik 3 strain
(Bififidobacterium breve M-16V, Bififidobacterium
longum subsp. infantis M-63, and Bififidobacterium
longum subsp. longum BB536), sebanyak 3 × 109 (i.e.,
3 billion) CFU per hari dari Morinaga Milk Industry
Co., Ltd., Japan.
Comparison, Control Kelompok Placebo (31) diberikan Maltodextrin
Outcome Primer : Jumlah Patogen Poten saat T3 (2 minggu
setelah pemberian suplementasi probiotik) di feses
(Clostridiaceae,Enterobacteriaceae,Enterococcaceae,
Pseudomonaceae,Staphylococcaeae,Streptococcaceae
, and Yersiniaceae)
Sekunder : Mikrobiota saat T1, T2, dan T4 ; kadar
SCFA di T1,T2,T3, dan T4 ; serta keluaran klinis
jangka pendek saat awal berada di NICU.